文献速递肿瘤 PET/CT

18F-FDG PET/CT对阴茎癌淋巴结分期的诊断性能

Diagnostic Performance of 18F-FDG PET/CT for Lymph Node Staging in Penile Cancer.
PubMed 文献 · Clin Nucl Med · 2022-01-01

该系统综述与Meta分析检索截至2021年8月31日的PubMed、Cochrane和Embase数据库,纳入12项研究共479例阴茎癌患者,评估18F-FDG PET/CT检测淋巴结转移的诊断准确性。汇总敏感度为0.87(95%CI 0.79-0.92),汇总特异度为0.88(95%CI 0.79-0.93),LR+为7.2(95%CI 3.9-13.1),LR-为0.15(95%CI 0.1-0.24),诊断比值比为47(95%CI 19-116)。作者认为18F-FDG PET/CT对阴茎癌转移性淋巴结检测显示良好的诊断性能,且对腹股沟和盆腔淋巴结转移的诊断准确性相似。

要点

  • 18F-FDG PET/CT检测阴茎癌转移性淋巴结的汇总敏感度为0.87(95%CI 0.79-0.92),汇总特异度为0.88(95%CI 0.79-0.93)。
  • 汇总LR+为7.2(95%CI 3.9-13.1),LR-为0.15(95%CI 0.1-0.24),诊断比值比为47(95%CI 19-116)。
  • 18F-FDG PET/CT对腹股沟和盆腔淋巴结转移的诊断准确性相似。

核心结论

  • 18F-FDG PET/CT对阴茎癌患者转移性淋巴结的检测显示出良好的诊断性能。
  • 18F-FDG PET/CT对阴茎癌患者腹股沟和盆腔淋巴结转移的检测显示出相似的诊断准确性。

研究设计与样本

  • 该系统综述与Meta分析检索PubMed、Cochrane数据库和Embase数据库,检索时间从各库最早收录日期至2021年8月31日。
  • 纳入评估18F-FDG PET/CT检测阴茎癌患者转移性淋巴结诊断性能的研究,共12项研究、479例患者。
  • 汇总各研究的敏感度和特异度,计算阳性似然比(LR+)和阴性似然比(LR-),并构建汇总受试者工作特征曲线。

主要发现

  • 12项研究共479例患者,18F-FDG PET/CT的汇总敏感度为0.87(95%CI 0.79-0.92),汇总特异度为0.88(95%CI 0.79-0.93)。
  • 似然比合成得出总体LR+为7.2(95%CI 3.9-13.1),LR-为0.15(95%CI 0.1-0.24)。
  • 汇总诊断比值比为47(95%CI 19-116)。
  • 在Meta回归分析中,没有变量是研究异质性的来源。

关键数值与推荐

  • 18F-FDG PET/CT检测阴茎癌转移性淋巴结的汇总敏感度为0.87(95%CI 0.79-0.92)。
  • 18F-FDG PET/CT检测阴茎癌转移性淋巴结的汇总特异度为0.88(95%CI 0.79-0.93)。
  • 汇总LR+为7.2(95%CI 3.9-13.1),汇总LR-为0.15(95%CI 0.1-0.24)。
  • 汇总诊断比值比为47(95%CI 19-116)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of the current study was to evaluate the diagnostic accuracies of 18F-FDG PET/CT for detection of lymph node (LN) metastasis in penile cancer (PeCA) patients through a systematic review and meta-analysis. PATIENTS AND METHODS: The PubMed, Cochrane database, and Embase database, from the earliest available date of indexing through August 31, 2021, were searched for studies evaluating diagnostic performance of 18F-FDG PET/CT for detection of metastatic LN in PeCA patients. We determined the sensitivities and specificities across studies, calculated positive and negative likelihood ratios (LR+ and LR-, respectively), and constructed summary receiver operating characteristic curves. RESULTS: Across 12 studies (479 patients), the pooled sensitivity of 18F-FDG PET/CT was 0.87 (95% confidence interval [CI], 0.79-0.92) and the pooled specificity was 0.88 (95% CI, 0.79-0.93). Likelihood ratio syntheses gave an overall LR+ of 7.2 (95% CI, 3.9-13.1) and LR- of 0.15 (95% CI, 0.1-0.24). The pooled diagnostic odds ratio was 47 (95% CI, 19-116). In meta-regression analysis, no variable was the source of the study heterogeneity. CONCLUSIONS: 18F-FDG PET/CT showed a good diagnostic performances for detection of metastatic LN in PeCA patients. Also, 18F-FDG PET/CT revealed similar diagnostic accuracy for detection of inguinal and pelvic LN metastasis in PeCA patients.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lee SW, Kim SJ. Diagnostic Performance of 18F-FDG PET/CT for Lymph Node Staging in Penile Cancer. Clin Nucl Med. 2022. PMID: 35143458. doi:10.1097/RLU.0000000000004081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。